If you’re starting a weight loss journey, you might have stumbled upon tirzepatide — the drug approved by the FDA (U.S. Food and Drug Administration) under the brand names Mounjaro and Zepbound.

Tirzepatide is the active ingredient in Eli ... will be restricted from making what are essentially copies of the brand-name version. These copies use the same active ingredient — in this ...

They are regulated by FDA guidelines. Those "off-ramp periods are appreciated" because it gives patients time to switch to brand-name tirzepatide, said Tenille Davis, chief advocacy officer for trade ...

People claim the viral "natural Mounjaro" drink — honey, lemon, water, and ginger — makes you lose weight. Here's what an ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

If you’re starting a weight loss journey, you might have stumbled upon tirzepatide — the drug approved by the FDA (U.S. Food ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.